Global Microneedle Flu Vaccine Supply, Demand and Key Producers, 2024-2030
Page: 103
Published Date: 29 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The global Microneedle Flu Vaccine market size is expected to reach $ 2095.3 million by 2030, rising at a market growth of 5.3% CAGR during the forecast period (2024-2030).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.
This report studies the global Microneedle Flu Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Microneedle Flu Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Microneedle Flu Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Microneedle Flu Vaccine total production and demand, 2019-2030, (K Dose)
Global Microneedle Flu Vaccine total production value, 2019-2030, (USD Million)
Global Microneedle Flu Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Dose)
Global Microneedle Flu Vaccine consumption by region & country, CAGR, 2019-2030 & (K Dose)
U.S. VS China: Microneedle Flu Vaccine domestic production, consumption, key domestic manufacturers and share
Global Microneedle Flu Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Dose)
Global Microneedle Flu Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Dose)
Global Microneedle Flu Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Dose).
This reports profiles key players in the global Microneedle Flu Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GC Pharma, Debiotech, NanoPass Technologies, Corium International, Becton Dickinson and Company, FluGen, CosMED Pharmaceuticals and Microdermics and OraSure Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Microneedle Flu Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Microneedle Flu Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Microneedle Flu Vaccine Market, Segmentation by Type
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
Global Microneedle Flu Vaccine Market, Segmentation by Application
Influenza A
Influenza B
Companies Profiled:
Sanofi
GC Pharma
Debiotech
NanoPass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies
Key Questions Answered
1. How big is the global Microneedle Flu Vaccine market?
2. What is the demand of the global Microneedle Flu Vaccine market?
3. What is the year over year growth of the global Microneedle Flu Vaccine market?
4. What is the production and production value of the global Microneedle Flu Vaccine market?
5. Who are the key producers in the global Microneedle Flu Vaccine market?
Table of Contents
1 Supply Summary
1.1 Microneedle Flu Vaccine Introduction
1.2 World Microneedle Flu Vaccine Supply & Forecast
1.2.1 World Microneedle Flu Vaccine Production Value (2019 & 2023 & 2030)
1.2.2 World Microneedle Flu Vaccine Production (2019-2030)
1.2.3 World Microneedle Flu Vaccine Pricing Trends (2019-2030)
1.3 World Microneedle Flu Vaccine Production by Region (Based on Production Site)
1.3.1 World Microneedle Flu Vaccine Production Value by Region (2019-2030)
1.3.2 World Microneedle Flu Vaccine Production by Region (2019-2030)
1.3.3 World Microneedle Flu Vaccine Average Price by Region (2019-2030)
1.3.4 North America Microneedle Flu Vaccine Production (2019-2030)
1.3.5 Europe Microneedle Flu Vaccine Production (2019-2030)
1.3.6 China Microneedle Flu Vaccine Production (2019-2030)
1.3.7 Japan Microneedle Flu Vaccine Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Microneedle Flu Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Microneedle Flu Vaccine Major Market Trends
2 Demand Summary
2.1 World Microneedle Flu Vaccine Demand (2019-2030)
2.2 World Microneedle Flu Vaccine Consumption by Region
2.2.1 World Microneedle Flu Vaccine Consumption by Region (2019-2024)
2.2.2 World Microneedle Flu Vaccine Consumption Forecast by Region (2025-2030)
2.3 United States Microneedle Flu Vaccine Consumption (2019-2030)
2.4 China Microneedle Flu Vaccine Consumption (2019-2030)
2.5 Europe Microneedle Flu Vaccine Consumption (2019-2030)
2.6 Japan Microneedle Flu Vaccine Consumption (2019-2030)
2.7 South Korea Microneedle Flu Vaccine Consumption (2019-2030)
2.8 ASEAN Microneedle Flu Vaccine Consumption (2019-2030)
2.9 India Microneedle Flu Vaccine Consumption (2019-2030)
3 World Microneedle Flu Vaccine Manufacturers Competitive Analysis
3.1 World Microneedle Flu Vaccine Production Value by Manufacturer (2019-2024)
3.2 World Microneedle Flu Vaccine Production by Manufacturer (2019-2024)
3.3 World Microneedle Flu Vaccine Average Price by Manufacturer (2019-2024)
3.4 Microneedle Flu Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Microneedle Flu Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Microneedle Flu Vaccine in 2023
3.5.3 Global Concentration Ratios (CR8) for Microneedle Flu Vaccine in 2023
3.6 Microneedle Flu Vaccine Market: Overall Company Footprint Analysis
3.6.1 Microneedle Flu Vaccine Market: Region Footprint
3.6.2 Microneedle Flu Vaccine Market: Company Product Type Footprint
3.6.3 Microneedle Flu Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Microneedle Flu Vaccine Production Value Comparison
4.1.1 United States VS China: Microneedle Flu Vaccine Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Microneedle Flu Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Microneedle Flu Vaccine Production Comparison
4.2.1 United States VS China: Microneedle Flu Vaccine Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Microneedle Flu Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Microneedle Flu Vaccine Consumption Comparison
4.3.1 United States VS China: Microneedle Flu Vaccine Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Microneedle Flu Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Microneedle Flu Vaccine Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Microneedle Flu Vaccine Production Value (2019-2024)
4.4.3 United States Based Manufacturers Microneedle Flu Vaccine Production (2019-2024)
4.5 China Based Microneedle Flu Vaccine Manufacturers and Market Share
4.5.1 China Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Microneedle Flu Vaccine Production Value (2019-2024)
4.5.3 China Based Manufacturers Microneedle Flu Vaccine Production (2019-2024)
4.6 Rest of World Based Microneedle Flu Vaccine Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Microneedle Flu Vaccine Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Microneedle Flu Vaccine Production (2019-2024)
5 Market Analysis by Type
5.1 World Microneedle Flu Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Solid Microneedle
5.2.2 Hollow Microneedle
5.2.3 Coated Microneedle
5.2.4 Dissolving Microneedle
5.3 Market Segment by Type
5.3.1 World Microneedle Flu Vaccine Production by Type (2019-2030)
5.3.2 World Microneedle Flu Vaccine Production Value by Type (2019-2030)
5.3.3 World Microneedle Flu Vaccine Average Price by Type (2019-2030)
6 Market Analysis by Application
6.1 World Microneedle Flu Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Influenza A
6.2.2 Influenza B
6.3 Market Segment by Application
6.3.1 World Microneedle Flu Vaccine Production by Application (2019-2030)
6.3.2 World Microneedle Flu Vaccine Production Value by Application (2019-2030)
6.3.3 World Microneedle Flu Vaccine Average Price by Application (2019-2030)
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Microneedle Flu Vaccine Product and Services
7.1.4 Sanofi Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 GC Pharma
7.2.1 GC Pharma Details
7.2.2 GC Pharma Major Business
7.2.3 GC Pharma Microneedle Flu Vaccine Product and Services
7.2.4 GC Pharma Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 GC Pharma Recent Developments/Updates
7.2.6 GC Pharma Competitive Strengths & Weaknesses
7.3 Debiotech
7.3.1 Debiotech Details
7.3.2 Debiotech Major Business
7.3.3 Debiotech Microneedle Flu Vaccine Product and Services
7.3.4 Debiotech Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Debiotech Recent Developments/Updates
7.3.6 Debiotech Competitive Strengths & Weaknesses
7.4 NanoPass Technologies
7.4.1 NanoPass Technologies Details
7.4.2 NanoPass Technologies Major Business
7.4.3 NanoPass Technologies Microneedle Flu Vaccine Product and Services
7.4.4 NanoPass Technologies Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 NanoPass Technologies Recent Developments/Updates
7.4.6 NanoPass Technologies Competitive Strengths & Weaknesses
7.5 Corium International
7.5.1 Corium International Details
7.5.2 Corium International Major Business
7.5.3 Corium International Microneedle Flu Vaccine Product and Services
7.5.4 Corium International Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Corium International Recent Developments/Updates
7.5.6 Corium International Competitive Strengths & Weaknesses
7.6 Becton Dickinson and Company
7.6.1 Becton Dickinson and Company Details
7.6.2 Becton Dickinson and Company Major Business
7.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Product and Services
7.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Becton Dickinson and Company Recent Developments/Updates
7.6.6 Becton Dickinson and Company Competitive Strengths & Weaknesses
7.7 FluGen
7.7.1 FluGen Details
7.7.2 FluGen Major Business
7.7.3 FluGen Microneedle Flu Vaccine Product and Services
7.7.4 FluGen Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 FluGen Recent Developments/Updates
7.7.6 FluGen Competitive Strengths & Weaknesses
7.8 CosMED Pharmaceuticals
7.8.1 CosMED Pharmaceuticals Details
7.8.2 CosMED Pharmaceuticals Major Business
7.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Product and Services
7.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 CosMED Pharmaceuticals Recent Developments/Updates
7.8.6 CosMED Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Microdermics and OraSure Technologies
7.9.1 Microdermics and OraSure Technologies Details
7.9.2 Microdermics and OraSure Technologies Major Business
7.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product and Services
7.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Microdermics and OraSure Technologies Recent Developments/Updates
7.9.6 Microdermics and OraSure Technologies Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Microneedle Flu Vaccine Industry Chain
8.2 Microneedle Flu Vaccine Upstream Analysis
8.2.1 Microneedle Flu Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Microneedle Flu Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Microneedle Flu Vaccine Production Mode
8.6 Microneedle Flu Vaccine Procurement Model
8.7 Microneedle Flu Vaccine Industry Sales Model and Sales Channels
8.7.1 Microneedle Flu Vaccine Sales Model
8.7.2 Microneedle Flu Vaccine Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Microneedle Flu Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Microneedle Flu Vaccine Production Value by Region (2019-2024) & (USD Million)
Table 3. World Microneedle Flu Vaccine Production Value by Region (2025-2030) & (USD Million)
Table 4. World Microneedle Flu Vaccine Production Value Market Share by Region (2019-2024)
Table 5. World Microneedle Flu Vaccine Production Value Market Share by Region (2025-2030)
Table 6. World Microneedle Flu Vaccine Production by Region (2019-2024) & (K Dose)
Table 7. World Microneedle Flu Vaccine Production by Region (2025-2030) & (K Dose)
Table 8. World Microneedle Flu Vaccine Production Market Share by Region (2019-2024)
Table 9. World Microneedle Flu Vaccine Production Market Share by Region (2025-2030)
Table 10. World Microneedle Flu Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 11. World Microneedle Flu Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 12. Microneedle Flu Vaccine Major Market Trends
Table 13. World Microneedle Flu Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Dose)
Table 14. World Microneedle Flu Vaccine Consumption by Region (2019-2024) & (K Dose)
Table 15. World Microneedle Flu Vaccine Consumption Forecast by Region (2025-2030) & (K Dose)
Table 16. World Microneedle Flu Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Microneedle Flu Vaccine Producers in 2023
Table 18. World Microneedle Flu Vaccine Production by Manufacturer (2019-2024) & (K Dose)
Table 19. Production Market Share of Key Microneedle Flu Vaccine Producers in 2023
Table 20. World Microneedle Flu Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 21. Global Microneedle Flu Vaccine Company Evaluation Quadrant
Table 22. World Microneedle Flu Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Microneedle Flu Vaccine Production Site of Key Manufacturer
Table 24. Microneedle Flu Vaccine Market: Company Product Type Footprint
Table 25. Microneedle Flu Vaccine Market: Company Product Application Footprint
Table 26. Microneedle Flu Vaccine Competitive Factors
Table 27. Microneedle Flu Vaccine New Entrant and Capacity Expansion Plans
Table 28. Microneedle Flu Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Microneedle Flu Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Microneedle Flu Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Dose)
Table 31. United States VS China Microneedle Flu Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Dose)
Table 32. United States Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Microneedle Flu Vaccine Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Microneedle Flu Vaccine Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Microneedle Flu Vaccine Production (2019-2024) & (K Dose)
Table 36. United States Based Manufacturers Microneedle Flu Vaccine Production Market Share (2019-2024)
Table 37. China Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Microneedle Flu Vaccine Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Microneedle Flu Vaccine Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Microneedle Flu Vaccine Production (2019-2024) & (K Dose)
Table 41. China Based Manufacturers Microneedle Flu Vaccine Production Market Share (2019-2024)
Table 42. Rest of World Based Microneedle Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Microneedle Flu Vaccine Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Microneedle Flu Vaccine Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Microneedle Flu Vaccine Production (2019-2024) & (K Dose)
Table 46. Rest of World Based Manufacturers Microneedle Flu Vaccine Production Market Share (2019-2024)
Table 47. World Microneedle Flu Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Microneedle Flu Vaccine Production by Type (2019-2024) & (K Dose)
Table 49. World Microneedle Flu Vaccine Production by Type (2025-2030) & (K Dose)
Table 50. World Microneedle Flu Vaccine Production Value by Type (2019-2024) & (USD Million)
Table 51. World Microneedle Flu Vaccine Production Value by Type (2025-2030) & (USD Million)
Table 52. World Microneedle Flu Vaccine Average Price by Type (2019-2024) & (US$/Dose)
Table 53. World Microneedle Flu Vaccine Average Price by Type (2025-2030) & (US$/Dose)
Table 54. World Microneedle Flu Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Microneedle Flu Vaccine Production by Application (2019-2024) & (K Dose)
Table 56. World Microneedle Flu Vaccine Production by Application (2025-2030) & (K Dose)
Table 57. World Microneedle Flu Vaccine Production Value by Application (2019-2024) & (USD Million)
Table 58. World Microneedle Flu Vaccine Production Value by Application (2025-2030) & (USD Million)
Table 59. World Microneedle Flu Vaccine Average Price by Application (2019-2024) & (US$/Dose)
Table 60. World Microneedle Flu Vaccine Average Price by Application (2025-2030) & (US$/Dose)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Microneedle Flu Vaccine Product and Services
Table 64. Sanofi Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. GC Pharma Basic Information, Manufacturing Base and Competitors
Table 68. GC Pharma Major Business
Table 69. GC Pharma Microneedle Flu Vaccine Product and Services
Table 70. GC Pharma Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. GC Pharma Recent Developments/Updates
Table 72. GC Pharma Competitive Strengths & Weaknesses
Table 73. Debiotech Basic Information, Manufacturing Base and Competitors
Table 74. Debiotech Major Business
Table 75. Debiotech Microneedle Flu Vaccine Product and Services
Table 76. Debiotech Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Debiotech Recent Developments/Updates
Table 78. Debiotech Competitive Strengths & Weaknesses
Table 79. NanoPass Technologies Basic Information, Manufacturing Base and Competitors
Table 80. NanoPass Technologies Major Business
Table 81. NanoPass Technologies Microneedle Flu Vaccine Product and Services
Table 82. NanoPass Technologies Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. NanoPass Technologies Recent Developments/Updates
Table 84. NanoPass Technologies Competitive Strengths & Weaknesses
Table 85. Corium International Basic Information, Manufacturing Base and Competitors
Table 86. Corium International Major Business
Table 87. Corium International Microneedle Flu Vaccine Product and Services
Table 88. Corium International Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Corium International Recent Developments/Updates
Table 90. Corium International Competitive Strengths & Weaknesses
Table 91. Becton Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 92. Becton Dickinson and Company Major Business
Table 93. Becton Dickinson and Company Microneedle Flu Vaccine Product and Services
Table 94. Becton Dickinson and Company Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Becton Dickinson and Company Recent Developments/Updates
Table 96. Becton Dickinson and Company Competitive Strengths & Weaknesses
Table 97. FluGen Basic Information, Manufacturing Base and Competitors
Table 98. FluGen Major Business
Table 99. FluGen Microneedle Flu Vaccine Product and Services
Table 100. FluGen Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. FluGen Recent Developments/Updates
Table 102. FluGen Competitive Strengths & Weaknesses
Table 103. CosMED Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. CosMED Pharmaceuticals Major Business
Table 105. CosMED Pharmaceuticals Microneedle Flu Vaccine Product and Services
Table 106. CosMED Pharmaceuticals Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. CosMED Pharmaceuticals Recent Developments/Updates
Table 108. Microdermics and OraSure Technologies Basic Information, Manufacturing Base and Competitors
Table 109. Microdermics and OraSure Technologies Major Business
Table 110. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product and Services
Table 111. Microdermics and OraSure Technologies Microneedle Flu Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Global Key Players of Microneedle Flu Vaccine Upstream (Raw Materials)
Table 113. Microneedle Flu Vaccine Typical Customers
Table 114. Microneedle Flu Vaccine Typical Distributors
List of Figure
Figure 1. Microneedle Flu Vaccine Picture
Figure 2. World Microneedle Flu Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Microneedle Flu Vaccine Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Microneedle Flu Vaccine Production (2019-2030) & (K Dose)
Figure 5. World Microneedle Flu Vaccine Average Price (2019-2030) & (US$/Dose)
Figure 6. World Microneedle Flu Vaccine Production Value Market Share by Region (2019-2030)
Figure 7. World Microneedle Flu Vaccine Production Market Share by Region (2019-2030)
Figure 8. North America Microneedle Flu Vaccine Production (2019-2030) & (K Dose)
Figure 9. Europe Microneedle Flu Vaccine Production (2019-2030) & (K Dose)
Figure 10. China Microneedle Flu Vaccine Production (2019-2030) & (K Dose)
Figure 11. Japan Microneedle Flu Vaccine Production (2019-2030) & (K Dose)
Figure 12. Microneedle Flu Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Microneedle Flu Vaccine Consumption (2019-2030) & (K Dose)
Figure 15. World Microneedle Flu Vaccine Consumption Market Share by Region (2019-2030)
Figure 16. United States Microneedle Flu Vaccine Consumption (2019-2030) & (K Dose)
Figure 17. China Microneedle Flu Vaccine Consumption (2019-2030) & (K Dose)
Figure 18. Europe Microneedle Flu Vaccine Consumption (2019-2030) & (K Dose)
Figure 19. Japan Microneedle Flu Vaccine Consumption (2019-2030) & (K Dose)
Figure 20. South Korea Microneedle Flu Vaccine Consumption (2019-2030) & (K Dose)
Figure 21. ASEAN Microneedle Flu Vaccine Consumption (2019-2030) & (K Dose)
Figure 22. India Microneedle Flu Vaccine Consumption (2019-2030) & (K Dose)
Figure 23. Producer Shipments of Microneedle Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Microneedle Flu Vaccine Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Microneedle Flu Vaccine Markets in 2023
Figure 26. United States VS China: Microneedle Flu Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Microneedle Flu Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Microneedle Flu Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Microneedle Flu Vaccine Production Market Share 2023
Figure 30. China Based Manufacturers Microneedle Flu Vaccine Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Microneedle Flu Vaccine Production Market Share 2023
Figure 32. World Microneedle Flu Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Microneedle Flu Vaccine Production Value Market Share by Type in 2023
Figure 34. Solid Microneedle
Figure 35. Hollow Microneedle
Figure 36. Coated Microneedle
Figure 37. Dissolving Microneedle
Figure 38. World Microneedle Flu Vaccine Production Market Share by Type (2019-2030)
Figure 39. World Microneedle Flu Vaccine Production Value Market Share by Type (2019-2030)
Figure 40. World Microneedle Flu Vaccine Average Price by Type (2019-2030) & (US$/Dose)
Figure 41. World Microneedle Flu Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Microneedle Flu Vaccine Production Value Market Share by Application in 2023
Figure 43. Influenza A
Figure 44. Influenza B
Figure 45. World Microneedle Flu Vaccine Production Market Share by Application (2019-2030)
Figure 46. World Microneedle Flu Vaccine Production Value Market Share by Application (2019-2030)
Figure 47. World Microneedle Flu Vaccine Average Price by Application (2019-2030) & (US$/Dose)
Figure 48. Microneedle Flu Vaccine Industry Chain
Figure 49. Microneedle Flu Vaccine Procurement Model
Figure 50. Microneedle Flu Vaccine Sales Model
Figure 51. Microneedle Flu Vaccine Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi GC Pharma Debiotech NanoPass Technologies Corium International Becton Dickinson and Company FluGen CosMED Pharmaceuticals Microdermics and OraSure Technologies
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>